Inhibition of microRNA-210 provides neuroprotection in hypoxic-ischemic brain injury in neonatal rats

Neurobiology of Disease

Volumn 89, Issue , 2016, Pages 202-212

  Ma, Qingyi ^a   Dasgupta, Chiranjib ^a   Li, Yong ^a   Bajwa, Nikita M ^b   Xiong, Fuxia ^a   Harding, Benjamin ^c   Hartman, Richard ^b   Zhang, Lubo ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOMA LINDA UNIVERSITY   (United States)

^c LOMA LINDA UNIVERSITY CHILDREN S HOSPITAL   (United States)

Author keywords

Complementary locked nucleic acid (LNA) oligonucleotides; Glucocorticoid receptor; Intranasal delivery; MicroRNA 210; Neonatal hypoxic ischemic brain injury; Neuroprotection

Indexed keywords

GLUCOCORTICOID RECEPTOR; MICRORNA 210; 3' UNTRANSLATED REGION; LOCKED NUCLEIC ACID; MICRORNA; MIRN210 MICRORNA, RAT; NEUROPROTECTIVE AGENT; OLIGONUCLEOTIDE;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION SIZE; CONTROLLED STUDY; DOWN REGULATION; GENE SEQUENCE; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; HYPOXIC ISCHEMIC ENCEPHALOPATHY; MOTOR PERFORMANCE; NERVE CELL NECROSIS; NEUROPATHOLOGY; NEUROPROTECTION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SPATIAL MEMORY; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; BRAIN; GENETICS; HYPOXIA-ISCHEMIA, BRAIN; METABOLISM;

3' UNTRANSLATED REGIONS; ANIMALS; ANIMALS, NEWBORN; BRAIN; HYPOXIA-ISCHEMIA, BRAIN; MICRORNAS; NEUROPROTECTIVE AGENTS; OLIGONUCLEOTIDES; RATS; RECEPTORS, GLUCOCORTICOID;

EID: 84958255872     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2016.02.011     Document Type: Article

References (42)

1. Azzopardi D.V., et al. Moderate hypothermia to treat perinatal asphyxial encephalopathy. N. Engl. J. Med. 2009, 361:1349-1358.
2. Brandeis R., et al. The use of the Morris Water Maze in the study of memory and learning. Int. J. Neurosci. 1989, 48:29-69.
3. Cai Z., et al. Intranasal administration of insulin-like growth factor-1 protects against lipopolysaccharide-induced injury in the developing rat brain. Neuroscience 2011, 194:195-207.
4. Chan S.Y., et al. MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2. Cell Metab. 2009, 10:273-284.
5. Chan Y.C., et al. miR-210: the master hypoxamir. Microcirculation 2012, 19:215-223.
6. Chen K.S., et al. Synaptic loss in cognitively impaired aged rats is ameliorated by chronic human nerve growth factor infusion. Neuroscience 1995, 68:19-27.
7. Chio C.C., et al. MicroRNA-210 targets antiapoptotic Bcl-2 expression and mediates hypoxia-induced apoptosis of neuroblastoma cells. Arch. Toxicol. 2013, 87:459-468.
8. Cooper P.R., et al. Efflux of monoclonal antibodies from rat brain by neonatal Fc receptor, FcRn. Brain Res. 2013, 1534:13-21.
9. Dasgupta C., et al. Chronic hypoxia during gestation causes epigenetic repression of the estrogen receptor-alpha gene in ovine uterine arteries via heightened promoter methylation. Hypertension 2012, 60:697-704.
10. D'Hooge R., De Deyn P.P. Applications of the Morris water maze in the study of learning and memory. Brain Res. Brain Res. Rev. 2001, 36:60-90.
11. Fasanaro P., et al. MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J. Biol. Chem. 2008, 283:15878-15883.
12. Fernandez-Lopez D., et al. Mechanisms of perinatal arterial ischemic stroke. J. Cereb. Blood Flow Metab. 2014, 34:921-932.
13. Gonzalez-Rodriguez P.J., et al. Dexamethasone protects neonatal hypoxic-ischemic brain injury via L-PGDS-dependent PGD2-DP1-pERK signaling pathway. PLoS ONE 2014, 9.
14. Gonzalez-Rodriguez P.J., et al. Fetal hypoxia increases vulnerability of hypoxic-ischemic brain injury in neonatal rats: role of glucocorticoid receptors. Neurobiol. Dis. 2014, 65:172-179.
15. Hartman R.E., et al. Motor and cognitive deficits in mice bred to have low or high blood pressure. Physiol. Behav. 2012, 105:1092-1097.
16. Higgins R.D., et al. Hypothermia and other treatment options for neonatal encephalopathy: an executive summary of the Eunice Kennedy Shriver NICHD workshop. J. Pediatr. 2011, 159(851-858).
17. Hollander J.A., et al. Striatal microRNA controls cocaine intake through CREB signalling. Nature 2010, 466:197-202.
18. Jacobs S.E., et al. Whole-body hypothermia for term and near-term newborns with hypoxic-ischemic encephalopathy: a randomized controlled trial. Arch. Pediatr. Adolesc. Med. 2011, 165:692-700.
19. Jeyaseelan K., et al. MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion. Stroke 2008, 39:959-966.
20. Jimenez-Mateos E.M., et al. Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects. Nat. Med. 2012, 18:1087-1094.
21. Kamper J.E., et al. Juvenile traumatic brain injury evolves into a chronic brain disorder: behavioral and histological changes over 6 months. Exp. Neurol. 2013, 250:8-19.
22. Kim H.W., et al. Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2. J. Biol. Chem. 2009, 284:33161-33168.
23. Kim I.D., et al. Intranasal delivery of HMGB1 siRNA confers target gene knockdown and robust neuroprotection in the postischemic brain. Mol. Ther. 2012, 20:829-839.
24. Kosik K.S. The neuronal microRNA system. Nat. Rev. Neurosci. 2006, 7:911-920.
25. Kosik K.S., Krichevsky A.M. The elegance of the microRNAs: a neuronal perspective. Neuron 2005, 47:779-782.
26. Lee A.S., et al. A double dissociation revealing bidirectional competition between striatum and hippocampus during learning. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:17163-17168.
27. Li Y., et al. Fetal stress and programming of hypoxic/ischemic-sensitive phenotype in the neonatal brain: mechanisms and possible interventions. Prog. Neurobiol. 2012, 98:145-165.
28. Ma Q., Zhang L. Epigenetic programming of hypoxic-ischemic encephalopathy in response to fetal hypoxia. Prog. Neurobiol. 2015, 124:28-48.
29. Moon J.M., et al. Inhibition of microRNA-181 reduces forebrain ischemia-induced neuronal loss. J. Cereb. Blood Flow Metab. 2013, 33:1976-1982.
30. Perez A.P., et al. Increased brain radioactivity by intranasal P-labeled siRNA dendriplexes within in situ-forming mucoadhesive gels. Int. J. Nanomedicine 2012, 7:1373-1385.
31. Preibisch S., et al. Globally optimal stitching of tiled 3D microscopic image acquisitions. Bioinformatics 2009, 25:1463-1465.
32. Prusky G.T., et al. Reduced visual acuity impairs place but not cued learning in the Morris water task. Behav. Brain Res. 2000, 116:135-140.
33. Rat D., et al. Neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP) slows down Alzheimer's disease-like pathology in amyloid precursor protein-transgenic mice. FASEB J. 2011, 25:3208-3218.
34. Rice J.E., et al. The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann. Neurol. 1981, 9:131-141.
35. Shankaran S., et al. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N. Engl. J. Med. 2005, 353:1574-1584.
36. van Velthoven C.T., et al. Mesenchymal stem cell transplantation attenuates brain injury after neonatal stroke. Stroke 2013, 44:1426-1432.
37. Verklan M.T. The chilling details: hypoxic-ischemic encephalopathy. J. Perinat. Neonatal Nurs. 2009, 23:59-68. quiz 69-70.
38. Yager J.Y., Ashwal S. Animal models of perinatal hypoxic-ischemic brain damage. Pediatr. Neurol. 2009, 40:156-167.
39. Yang D., et al. Intranasal delivery of cell-penetrating anti-NF-kappaB peptides (Tat-NBD) alleviates infection-sensitized hypoxic-ischemic brain injury. Exp. Neurol. 2013, 247:447-455.
40. Yang D., et al. Taming neonatal hypoxic-ischemic brain injury by intranasal delivery of plasminogen activator inhibitor-1. Stroke 2013, 44:2623-2627.
41. Zhang Y., et al. Elevated levels of hypoxia-inducible microRNA-210 in pre-eclampsia: new insights into molecular mechanisms for the disease. J. Cell. Mol. Med. 2012, 16:249-259.
42. Zhao B.Q., et al. Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat. Med. 2006, 12:441-445.